Newest first. 5.2k questions across 107 tags.
Setup, so nobody has to ask: 74 kg · 1,400 kcal. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far,…
Stated plainly: TRIUMPH-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I am working with: SURMOUNT-OSA · 10 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I have: FGP · Xi’an Mokemei Biotechnology. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Concretely: Tianjin · the United Kingdom. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: Tianjin · the United Kingdom. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Details up front: cagrilintide · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Concretely: KP · Bachem Holding (Suzhou). I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
I have started asking labs for "the system suitability data" and getting back either silence, a shrug, or a screenshot of six retention times. I clearly do not know…
Concretely: 10 mg/mL · oral semaglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Conditions: 0.25 mg · four weeks · constipation. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
The case in front of me: 10 mg · 0.5 mL · 0.9% sodium chloride · a GLP-1 receptor agonist. I want to decide this in advance so that I am not deciding it under…
This matters because it predicts what a related molecule should do. This is one of those things that everyone repeats and nobody derives. This matters practically,…
Concretely: 0.25 mg · liraglutide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
Concretely: SURMOUNT-OSA · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
Conditions: list of related substances · SSA. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Concretely: semaglutide · a C4 column · survodutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The case in front of me: 10 mg · 2.5 mL · 0.9% sodium chloride · mazdutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume…
What I am working with: tirzepatide · three weeks. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
The specifics, since they change the answer: 10 mg · ten weeks · reflux. I understand the observation; what I do not understand is the mechanism behind it. I have…
I would like to know how much of this is established and how much is a reasonable story. I have the document in front of me and I can read the numbers. What I cannot…
What I am working with: tirzepatide · three weeks · room temperature. I understand the observation; what I do not understand is the mechanism behind it. I have read…
Concretely: QYB · ecnoglutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed, which is…
The method section is present, which is unusual enough that I want to make use of it. I have read the primary source rather than the summary, which has left me with…